This inventor holds 2 USPTO granted patents. Top assignee: Lupin, Inc.. Active years: 2014-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014-2015
Title: Ashish Tiwari: Innovator in Pharmaceutical Compositions
Introduction
Ashish Tiwari is a notable inventor based in Pune, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of controlled release compositions. With a total of 2 patents to his name, Tiwari's work is recognized for its innovative approach to drug delivery systems.
Latest Patents
Tiwari's latest patents focus on controlled release pharmaceutical compositions of milnacipran. One of his notable inventions is a controlled release pharmaceutical composition that includes milnacipran or its pharmaceutically acceptable salts, combined with a hydrophobic release controlling agent. This composition is designed to release 90% of the total amount of milnacipran over a period of 8 to 20 hours under specific dissolution conditions. The process for preparing this composition involves creating a first layer that includes melting the hydrophobic agent and milnacipran, followed by cooling and sieving to obtain granules. A second layer is then prepared, which may include additional granules of the hydrophobic agent and milnacipran.
Career Highlights
Ashish Tiwari is currently associated with Lupin, Inc., a prominent player in the pharmaceutical industry. His work at Lupin has allowed him to focus on innovative drug formulations that enhance therapeutic efficacy and patient compliance.
Collaborations
Tiwari has collaborated with several professionals in his field, including coworkers Pandharinath Jadhav and Rajesh Kulkarni. These collaborations have contributed to the advancement of his research and the successful development of his patented compositions.
Conclusion
Ashish Tiwari's contributions to pharmaceutical innovations, particularly in controlled release formulations, highlight his role as a key inventor in the industry. His work continues to impact the field of drug delivery, showcasing the importance of innovation in improving patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
